Drugs / NTC015
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04759885 | Jun 2020 → Jul 2021 | — | NTC srl | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NTC015 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04759885 ↗ |
| Known as | Mannitol | “Phase II: NTC015 low dose (Mannitol 50 g)” NCT04759885 ↗ |